Skip to content
10-Q

Quarterly Report

T2 Biosystems, Inc.

0000950170-24-094135

← back to feed
Filed
Aug 8, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 5, 2024 17.48M sh
Shares Diluted Q2 2024 · Jun 30, 2024 14.1M sh
Shares Diluted Q2 2024 · Jun 30, 2024 9.6M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 809.17K sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 474.61K sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$20.92M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$25.33M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $4.25M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $15.69M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $16.08M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$5.9M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$37.77M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$28.04M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$36.42M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$49.89M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$39.66M
Current Liabilities Q2 2024 · Jun 30, 2024 $21.8M
Current Liabilities Q2 2024 · Dec 31, 2023 $56.15M
Total Liabilities Q2 2024 · Jun 30, 2024 $27.62M
Total Liabilities Q2 2024 · Dec 31, 2023 $62.83M
Current Assets Q2 2024 · Jun 30, 2024 $13M
Current Assets Q2 2024 · Dec 31, 2023 $25.19M
Total Assets Q2 2024 · Jun 30, 2024 $21.72M
Total Assets Q2 2024 · Dec 31, 2023 $34.8M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.64
Eps Diluted Q2 2024 · Jun 30, 2024 −$2.34
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$7.84
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$51.23
Eps Basic Q2 2024 · Jun 30, 2024 −$0.64
Eps Basic Q2 2024 · Jun 30, 2024 −$2.34
Eps Basic restated Q2 2024 · Jun 30, 2023 −$7.84
Eps Basic restated Q2 2024 · Jun 30, 2023 −$51.23
Sga Expense Q2 2024 · Jun 30, 2024 $5.47M
Sga Expense Q2 2024 · Jun 30, 2024 $12.21M
Sga Expense Q2 2024 · Jun 30, 2023 $6.3M
Sga Expense Q2 2024 · Jun 30, 2023 $13.6M
Rd Expense Q2 2024 · Jun 30, 2024 $3.36M
Rd Expense Q2 2024 · Jun 30, 2024 $7.08M
Rd Expense Q2 2024 · Jun 30, 2023 $3.85M
Rd Expense Q2 2024 · Jun 30, 2023 $8.32M
Net Income Q2 2024 · Jun 30, 2024 −$8.96M
Net Income Q2 2024 · Jun 30, 2024 −$22.5M
Net Income Q2 2024 · Mar 31, 2024 −$13.53M
Net Income Q2 2024 · Jun 30, 2023 −$6.35M
Net Income Q2 2024 · Jun 30, 2023 −$24.31M
Net Income Q2 2024 · Mar 31, 2023 −$17.97M
Operating Income Q2 2024 · Jun 30, 2024 −$9.58M
Operating Income Q2 2024 · Jun 30, 2024 −$22.18M
Operating Income Q2 2024 · Jun 30, 2023 −$13.05M
Operating Income Q2 2024 · Jun 30, 2023 −$26.74M
Revenue Q2 2024 · Jun 30, 2024 $1.95M
Revenue Q2 2024 · Jun 30, 2024 $4.01M
Revenue Q2 2024 · Jun 30, 2023 $1.96M
Revenue Q2 2024 · Jun 30, 2023 $4.04M
Capex Q2 2024 · Jun 30, 2023 $153K